"The deal will also give patients in Britain greater access to potentially life-extending drugs because the rules have been relaxed to allow the NHS to pay more for particular treatments."
"The government described it as a win for British patients, British businesses and the British economy, because it will help protect the UK's 50,000 pharmaceutical jobs and encourage drug companies to invest in research, development and production in the UK."
"Keir Starmer's willingness to pay more for medicines would lead to him taking an axe to the NHS to pacify Donald Trump and big pharma's demand for higher medicines prices."
A new UK-US medicines deal allows British drug exports to the US to avoid tariffs, benefiting pharmaceutical firms and patients. The NHS can now spend more on treatments, increasing the annual budget from £30,000 to £35,000 per patient. The government claims this will enhance patient access to life-extending drugs and protect pharmaceutical jobs in the UK. Critics, however, express concerns that this deal may lead to higher medicine prices and reduced funding for the NHS, with calls for caution regarding the implications for public health.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]